Tg Therapeutics (TGTX) Net Margin (2017 - 2026)
Tg Therapeutics (TGTX) posted quarterly Net Margin of 9.64% for Q1 2026, up 545.0% year-over-year from 1.5% in Q1 2025, and down 20.74% quarter-over-quarter from 12.17% in Q4 2025.
Tg Therapeutics (TGTX) Net Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' Net Margin history runs 10 years deep, the most recent figure standing at 9.64% for Q1 2026.
- In Q1 2026, Net Margin rose 545.0% year-over-year to 9.64%; the TTM figure through Mar 2026 stood at 66.01% (up 5380.0% YoY), while the FY2025 annual figure was 72.62%, up 6306.0% from the prior year.
- Net Margin for Q1 2026 stood at 9.64%, down from 12.17% in the prior quarter.
- The five-year high for Net Margin was 241.73% in Q3 2025, with the low at 94568.75% in Q4 2022.
- The 5-year median for Net Margin is 4.19% (2025), against an average of 8928.61%.
- The sharpest annual moves came in 2022 and 2023: Net Margin slumped 9043747 bps in 2022, then soared 9453844 bps in 2023.
- Tg Therapeutics' Net Margin stood at 94568.75% in 2022, then soared by 100 bps to 30.31% in 2023, then surged by 196 bps to 29.01% in 2024, then tumbled by 58 bps to 12.17% in 2025, then retreated by 21 bps to 9.64% in 2026.
- Business Quant data shows TGTX's Net Margin at 9.64% in Q1 2026, 12.17% in Q4 2025, and 241.73% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 3.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.22% |
| Mar 31, 2026 | 9.64% |
| Dec 31, 2025 | 12.17% |
| Sep 30, 2025 | 241.73% |
| Jun 30, 2025 | 19.97% |
| Mar 31, 2025 | 4.19% |
| Dec 31, 2024 | 29.01% |
| Sep 30, 2024 | 4.61% |
| Jun 30, 2024 | 9.33% |
| Mar 31, 2024 | -16.87% |
| Dec 31, 2023 | -30.31% |
| Sep 30, 2023 | 68.71% |
| Jun 30, 2023 | -296.19% |
| Mar 31, 2023 | -502.78% |
| Dec 31, 2022 | -94,568.75% |
| Sep 30, 2022 | -43,577.66% |
| Jun 30, 2022 | -9,466.33% |
| Mar 31, 2022 | -3,726.84% |
| Dec 31, 2021 | -4,131.28% |
| Sep 30, 2021 | -5,082.46% |